THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK ...
The global pharmaceutical market is undergoing a major transformation driven by innovation, rising healthcare demand, and ...
Clark County judge finds defendant's public statements were not made in good faith. The ruling caps months of legal proceedings brought by the inventor of a wellness technology used in over 700 ...
MMJ International Holdings Moves to Join Federal Lawsuit Challenging CMS Hemp-CBD Medicare Pilot as Preliminary Injunction Hearing Approaches. WASHINGTON, D.C. / ACCESS Newswire / April 11, 2026 / MMJ ...
Program Includes Establishing Pharmaceutical Manufacturing in the U.S., Procurement and Development of Treatment for ...
BFA Law is investigating ADMA Biologics after its stock plummeted 29% due to Culper Research channel stuffing claims, potentially violating federal securities laws. ADMA Biologics is an end-to-end ...
PharmNovo AB announces that the drug product for its lead candidate PN6047 has been manufactured for the upcoming Phase IIa proof-of-concept (PoC) study in neuropathic pain.PharmNovo is a ...
This record closing is the largest raise ever achieved by a fully independent European fund dedicated to Biopharma, ...
"As CMS Launches its $500 Cannabinoid "Engagement Incentive," MMJ International Holdings Warns of a Regulatory "Double ...
NR is the first among NR, NMN, and NAD+ to receive a pharmacopeial quality benchmark, reinforcing Niagen Bioscience’s leadership in NAD+ science and ingredient qualityLOS ANGELES--(BUSINESS ...
Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of ordinary shares of uniQure N.V. (NASDAQ: QURE) between September 24, 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results